EP3318258
COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.3.2014EP published:
13.5.2020EP application number:
17189252.4
EPO information:
European Patent Register
Max expiry date:
13.3.2034
Title:
COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS
Timeline
Today
14.3.2014EP application
13.5.2020EP Publication
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, North Chicago, IL 60064, US
Inventor
Name:
BERNSTEIN, Barry M.Address:
Mequon, WI 53092, US
Name:
DUTTA, SandeepAddress:
Lincolnshire, IL 60069, US
Name:
LIU, WeiAddress:
Mundelein, IL 60060, US
Name:
PODSADECKI, Thomas J.Address:
Northbrook, IL 60062, US
Name:
CAMPBELL, Andrew L.Address:
Lake Forest, IL 60045, US
Name:
MENON, Rajeev M.Address:
Buffalo Grove, IL 60089, US
Name:
LIN, Chih-WeiAddress:
Vernon Hills, IL 60061, US
Name:
WANG, TianliAddress:
Lake Bluff, IL 60044, US
Name:
AWNI, Walid M.Address:
Green Oaks, IL 60048, US
Name:
MENSING, SvenAddress:
68305 Mannheim, DE
Priority
Number:
201361783437 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 31/454, A61K 31/4985, A61K 31/7056, A61K 45/06, A61P 31/22